Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Sep 26, 2015
Results from clinical trials evaluating the Boston Scientific (NYSE: BSX) Lotus™ Valve System continue to show this advanced transcatheter aortic valve implantation (TAVI) therapy delivers...
-
Sep 10, 2015System includes first directional lead with current steering and expanded programming flexibility
Boston Scientific (NYSE: BSX) has received CE Mark for the Vercise™ Primary Cell (PC) Deep Brain Stimulation (DBS) System. The Vercise PC System is intended to provide precise neural targeting...
-
Sep 9, 2015I benefici comportati dalla termoplastica bronchiale perdurano per anni, anziché per ore, diversamente da quanto accade col solo trattamento farmacologico.
Una tecnologia rivoluzionaria di Boston Scientific per il trattamento dell'asma grave si è dimostrata sicura ed efficace nell'arco di almeno cinque anni, secondo i dati pubblicati online da...
-
Aug 31, 2015
Boston Scientific welcomes the updated ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death announced during ESC Congress 2015, the...
-
Aug 31, 2015
Boston Scientific accoglie l’aggiornamento delle linee guida ESC per la gestione dei pazienti affetti da aritmie ventricolari e per la prevenzione della morte cardiaca improvvisa annunciato...
-
Aug 31, 2015
Boston Scientific begrüßt die aktualisierten ESC-Leitlinien für die Behandlung von Patienten mit ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes. Diese wurden während...
-
Aug 31, 2015
Boston Scientific da la bienvenida a la actualización de las directrices de la ESC para tratar a pacientes con arritmias ventriculares y para prevenir la muerte súbita cardíaca, anunciadas...
-
Aug 24, 2015
Boston Scientific Corporation (NYSE: BSX) has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable...
-
Aug 24, 2015L’aggiornamento della documentazione consente la compatibilità retroattiva con le scansioni MRI per i sistemi ICD e CRT-D a più lunga durata del settore
Boston Scientific Corporation (NYSE: BSX) ha ricevuto il marchio CE per la compatibilità con la risonanza magnetica per immagini (MRI) per le attuali famiglie di sistemi di defibrillatori...
-
Aug 24, 2015Die aktualisierte Indikation gewährleistet eine rückwirkende MRT-Kompatibilität der seit langem etablierten ICD- und CRT-D-Systeme
Die Boston Scientific Corporation (NYSE: BSX) hat das CE-Zeichnen für die MRT-Tauglichkeit der aktuellen implantierbaren EL- und MINI-Kardioverter-Defibrillatoren (ICD) sowie für die...
-
Aug 24, 2015La denominación actualizada permite la retrocompatibilidad con las pruebas de RM de los sistemas de DCI y CRT-D más duraderos del sector
Boston Scientific Corporation (NYSE: BSX) ha recibido el marcado CE para su familia actual de desfibriladores cardioversores implantables (DCI) de larga duración (EL) y MINI, y del desfibrilador...
-
Aug 4, 2015
Boston Scientific Corporation (NYSE: BSX) has closed on the previously announced agreement with Endo International plc (NASDAQ: ENDP) (TSX: ENL) to purchase the American Medical Systems (AMS)...
-
Aug 4, 2015
Boston Scientific Corporation (NYSE: BSX) ha cerrado el acuerdo, previamente anunciado, con Endo International plc (NASDAQ: ENDP) (TSX: ENL) para la adquisición del negocio de andrología y salud...
-
Jul 22, 2015
First Guidewire Designed Specifically for TAVI/R Now Sized for Smaller Ventricles Boston Scientific (NYSE: BSX) announces CE Mark and FDA clearance for the Safari2™ Pre-Shaped Guidewire, a new...
-
Jun 23, 2015The new generation of subcutaneous defibrillators selected as most innovative in the field of cardiac electrophysiology.
MILAN, Italy, June 23, 2014 – Attendees of EHRA EUROPACE-CARDIOSTIM 2015, a global medical conference held recently in Milan, Italy, have selected the EMBLEM™ S-ICD System as the most...
-
Jun 23, 2015
Die Teilnehmer der EHRA EUROPACE-CARDIOSTIM 2015, einer globalen Konferenz, die kürzlich in Mailand stattfand, haben das EMBLEM™-S-ICD-System zum innovativsten Produkt zur Verbesserung der...
-
Jun 22, 2015
Boston Scientific (NYSE: BSX) has initiated a worldwide study to evaluate the rate and causes of shocks for patients implanted with the EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) for...
-
Jun 12, 2015Boston Scientific è lieta di invitarla alla presentazione stampa del nuovo sistema di protezione da morte cardiaca improvvisa “EMBLEM™” – defibrillatore impiantabile sottocutaneo (S-ICD)
SEGNI LA DATA IN AGENDA: 23 GIUGNO 2015 Milano Enterprise Hotel Corso Sempione, 91-93 20149 Milano, Italia Le presenteremo una esclusiva tecnologia salvavita. Il defibrillatore impiantabile...
-
Jun 10, 2015Please join us for a Boston Scientific press event. Protection from sudden cardiac death, just under the skin: the EMBLEM™ Subcutaneous ICD System
SAVE THE DATE: June 23, 2015. Milan, Italy. Enterprise Hotel Corso Sempione, 91-93 20149 Milan, Italy We would like to invite you to our press event on June 23, 2015 dedicated to an innovative,...
-
Jun 10, 2015Einladung zur Presseveranstaltung von Boston Scientific. Schutz vor plötzlichem Herzstillstand, direkt unter der Haut: das EMBLEM™ Subkutane-ICD System.
SAVE THE DATE: 23. Juni 2015. Mailand, Italien. Enterprise Hotel Corso Sempiore, 91-03 20149 Mailand, Italien Wir möchten Sie herzlich zu unserer Presseveranstaltung am 23. Juni 2015 rund um das...
-
Jun 10, 2015
¡RESERVA LA FECHA!: JUNIO 23, 2015. Milán, Italia. Enterprise Hotel Corso Sempione, 91-93 20149 Milán, Italia Es un placer invitarte al evento de prensa que tendrá lugar el próximo 23 de...
-
Jun 5, 2015El dispositivo de 16 contactos y batería desechable de alta capacidad más pequeña del mundo expande la oferta del sistema de estimulación de la médula espinal
Boston Scientific anuncia la comercialización del sistema Precision Novi™ para la estimulación de la médula espinal (EME) en la Sociedad Internacional de Neuromodulación en Montreal,...
-
Jun 4, 2015
World’s Smallest 16-Contact High-Capacity Primary Cell Device Expands Spinal Cord Stimulator System Offering Boston Scientific announces the European launch of the Precision Novi™ Spinal Cord...
-
Jun 4, 2015Das weltweit kleinste 16-Kontakt-Gerät mit Hochleistungs-Primärzelle erweitert das Angebot im Bereich der Rückenmarkstimulation
Im Rahmen des Kongresses der International Neuromodulation Society in Montreal, Kanada, kündigte Boston Scientific die europäische Markteinführung des Precision Novi™-Systems zur...
-
May 20, 2015
Compelling Results Presented at EuroPCR 2015 Add to Growing Body of Evidence Supporting Performance and Safety A new study evaluating the Boston Scientific (NYSE: BSX) Lotus™ Valve System...